Chinese tech giant Tencent’s first attempt in AI healthcare was the Miying platform, which has been a point of pride for CEO Huateng Ma since its 2017 launch. Supported by AI-powered medical imaging technologies, Miying assists doctors with the screening of esophageal cancer, pulmonary nodules, cervical cancer, etc. The platform has been well received in the AI and medical communities, with a fast-expanding market in Chinese top-tier AAA hospitals.
Artificial intelligence can now match or outperform human experts in diagnosis and referral on eye diseases, suggests a new paper from DeepMind. The UK-based, Google-owned research institute today released joint research results with the UK’s Moorfields Eye Hospital and UCL Institute of Ophthalmology, which present a new AI technique in the context of OCT imaging. The paper was published on Nature Medicine’s website.